GrowthCraft

Startup Funding

Early-stage startup founders reviewing financial projections and funding-readiness metrics before meeting with investors

How to Know If Your Startup Is Actually Ready to Raise Money

How to Know If Your Startup Is Actually Ready to Raise Money

Early-stage startup founders reviewing financial projections and funding-readiness metrics before meeting with investors
Before raising capital, founders should understand their customers, market, financials, business model, and the specific milestones funding will help achieve.

How to Know If Your Startup Is Actually Ready to Raise Money

Raising money can feel like the next obvious step for a startup. You have an idea, you have built something, you may have early customers, and now you need capital to move faster.

But needing money and being ready to raise money are not the same thing.

For an early-stage founder, one of the most important funding decisions is knowing whether outside capital will actually help the company reach its next meaningful milestone. Investors are not simply looking for startups that need cash. They are looking for evidence that additional capital can help a promising business become more valuable.

That distinction is at the heart of funding readiness.

The U.S. Securities and Exchange Commission specifically recommends that companies consider their capitalization table, financials, funding requirements, use of proceeds, investor strategy, advisors, and long-term vision before beginning a capital raise. The Small Business Administration similarly points to market research, financial projections, management capability, and due diligence as important parts of preparing for outside funding.

For first-time founders, the better question is not, “How do I raise money?”

It is, “What would make an investor believe that putting money into my company today is likely to produce a meaningful result tomorrow?”

Funding Is a Tool, Not the Goal

One of the easiest mistakes for a startup founder to make is treating fundraising as a milestone in itself.

Raising $500,000 does not mean the startup is successful. Raising $2 million does not mean the business has found product-market fit. Funding simply gives the company additional resources.

The real purpose of funding should be tied to a specific business outcome.

Perhaps you need capital to finish development of a product, hire the people required to deliver it, conduct a larger market test, expand customer acquisition, complete regulatory work, or reach a revenue milestone. Whatever the reason, you should be able to explain what the money will accomplish.

The SEC recommends that founders calculate their runway and have a clear plan for how the proceeds will be used.

A useful test is this:

If an investor gave you the money tomorrow, what would be measurably different about your company 12 to 18 months from now?

If you cannot answer that question, you may not be ready to raise.

Why Raising Money Too Early Can Hurt a Startup

More money does not automatically solve startup problems.

In fact, raising money before you understand your customer, business model, or market can make existing problems more expensive.

Suppose you raise $1 million before you know exactly who your best customer is. You now have money to hire employees, build features, spend on marketing, and increase operating expenses. But if the underlying customer assumptions are wrong, you can spend $1 million discovering what you could have learned for $50,000.

Early funding can also create pressure to grow before the company is ready. Investors expect progress. Employees are hired. Expenses increase. Expectations change. The founder can end up managing a larger organization before the basic business has been validated.

This does not mean founders should always wait until they are profitable or have significant revenue. Some startups need capital very early because they have substantial research, development, regulatory, manufacturing, or infrastructure requirements.

The question is whether you have enough evidence to justify the amount of capital you are seeking and whether the capital has a clearly defined job.

The Questions Investors Will Ask

You should be able to answer the basic investor questions before you start pitching.

Y Combinator’s seed fundraising guidance provides a useful framework that includes the problem, customer, solution, market, competition, traction, business model, team, and fundraising requirements.

Those questions generally come down to five areas:

  • Why this problem? Can you demonstrate that the problem is real, important, and painful enough for customers to address?
  • Why this solution? What have you built, and why is it meaningfully better, faster, cheaper, easier, or more valuable than existing alternatives?
  • Why this market? How large is the opportunity, and what evidence supports your market assumptions?
  • Why your company? Why are you and your team particularly qualified to solve this problem?
  • Why now and why funding? What has changed, what have you learned, and what will additional capital allow you to accomplish?

You do not need to have perfect answers. Early-stage companies rarely do. You do need to understand what you know, what you do not know, and what evidence supports your assumptions.

Evidence of Customer Demand

Customer demand is one of the strongest indicators of funding readiness.

That does not necessarily mean you need millions of dollars in revenue. Depending on the stage and type of company, useful evidence could include paying customers, signed contracts, pilot customers, repeat usage, preorders, strong customer retention, partnerships, letters of intent, or measurable engagement.

The important distinction is between what people say and what people do.

Someone telling you, “That’s a great idea,” is encouraging.

Someone agreeing to pay for it is much stronger evidence.

Techstars similarly emphasizes traction and evidence that customers want the product as important elements of a compelling investment case.

Before approaching investors, ask yourself:

  • Who has actually used the product?
  • Who has paid for it?
  • Who has used it more than once?
  • What percentage of customers continue using it?
  • What problem caused them to buy?
  • Why did customers choose you instead of an alternative?
  • What have customers asked you to improve?

Your answers create a much stronger story than a collection of assumptions.

Business Model Clarity

Investors need to understand how the company eventually makes money.

Your business model does not have to be perfect. It does need to be understandable.

Can you explain who pays, what they pay for, how much they pay, how frequently they pay, and what it costs you to deliver the product or service?

If your current model is expected to change, explain why.

A founder who says, “We haven’t figured out monetization yet,” may be describing a legitimate early-stage reality. But the founder should also be able to explain what has been tested and what needs to be learned next.

A strong early business model conversation might sound like this:

“We currently charge X for Y. We tested three pricing approaches with 20 customers. This option produced the strongest conversion and retention. We believe we can improve gross margins as volume increases.”

That demonstrates learning rather than pretending certainty.

Financial Understanding

You do not need to be an accountant to raise money.

You do need to understand your company’s financial reality.

At minimum, you should know your current cash balance, monthly expenses, cash burn, runway, revenue, gross margin if applicable, major cost categories, and the assumptions behind your financial projections.

You should also know exactly how much you are asking for and why.

The SEC specifically identifies financial statements, capitalization tables, runway, and a clear plan for the use of proceeds as important components of capital-raising preparation.

Your financial model should not exist simply because an investor expects to see a spreadsheet. It should help you make decisions.

For example, if you are raising $750,000, what does that money allow you to accomplish that $300,000 would not? What happens if you raise $1 million? What happens if you raise only $500,000?

Understanding these scenarios makes you a better capital allocator and a more credible founder.

The U.S. Small Business Administration’s business planning guidance (https://www.sba.gov/counseling/plan-your-business/) also recommends connecting funding requirements with financial projections and explaining the assumptions behind those projections.

Market Opportunity

A great product in a tiny or shrinking market may not produce the type of return some investors are looking for.

That does not mean every startup needs to claim a massive market. It means you need to understand the market you are entering.

Start with the actual customer.

How many potential customers exist? What do they currently spend to solve the problem? What alternatives are available? How competitive is the market? What trends could increase or decrease demand?

The SBA recommends examining demand, market size, pricing, competition, customer characteristics, and broader economic factors when conducting market research.

Be careful with the common “1% of a $10 billion market” argument. Investors generally need more than a large theoretical market number. They need to understand how your company can realistically capture a meaningful portion of that opportunity.

Founder and Team Readiness

At the earliest stages, investors are investing heavily in the people.

That does not mean you need a large team.

It means the people involved need to make sense for the company’s current stage and future challenges.

Who owns the technical work? Who understands customers? Who handles operations? Who is responsible for sales? What capabilities are missing?

If there is a major gap, acknowledge it.

A founder who understands the company’s weaknesses is often more credible than one who claims the team can do everything.

Research discussed in Harvard Business Review also highlights the importance investors place on startup teams during due diligence, alongside business model, market opportunity, and growth plans.

Legal and IP Considerations

Legal preparation is easy to overlook when you are focused on building the product.

It can become a serious problem during due diligence.

Before raising capital, you should know who owns the company, how equity is divided, whether founder agreements are documented, whether intellectual property belongs to the company, and whether important contracts are in place.

If contractors or employees created important technology, make sure the company has appropriate agreements addressing intellectual property ownership.

If your company relies on patents, trademarks, copyrights, proprietary technology, trade secrets, or other intellectual property, understand what has been protected and what remains exposed.

The SBA specifically identifies intellectual property plans, patents, legal documents, licenses, permits, contracts, and other supporting materials as information that may belong in a company’s funding documentation.

The SEC also recommends having experienced legal and accounting advisors involved in the capital-raising process.

This is an area where professional legal advice is particularly important. Securities laws can apply when a company sells equity or other securities, and the appropriate exemption and compliance requirements depend on the circumstances. The SEC provides current educational resources on exempt offerings and capital raising.

What Should Be Prepared Before Approaching Investors?

You do not need a giant data room before having your first investor conversation. You should, however, be prepared to support the story you are telling.

At a minimum, consider preparing:

A clear pitch deck. It should explain the problem, customer, solution, market, traction, business model, team, competitive landscape, and funding request. Y Combinator’s seed fundraising framework provides a useful starting structure.

A financial model. Your model should show historical performance where available, projected revenue and expenses, cash requirements, and the assumptions behind your projections.

A capitalization table. Know exactly who owns what before inviting new investors into the company.

Customer evidence. Organize your strongest evidence of demand, including revenue, customer growth, retention, pilots, contracts, partnerships, testimonials, or other meaningful indicators.

A use-of-funds plan. Explain where the money will go and what business milestones those expenditures are intended to produce.

A due diligence folder. Organize important corporate, financial, legal, intellectual property, customer, employee, and contractual documents so you can respond efficiently when investors begin asking questions.

The SBA describes due diligence as a process in which investors may examine management, markets, products and services, corporate governance documents, and financial statements.

A Practical Funding-Readiness Checklist

Before actively raising money, give yourself one point for every statement you can confidently answer “yes” to:

1. I can clearly explain the customer problem. I can identify the specific customer experiencing it and explain why the problem matters.

2. I have evidence that customers want the solution. I have more than opinions or survey responses. I have meaningful evidence such as usage, revenue, pilots, contracts, or other customer behavior.

3. I understand my business model. I know who pays, what they pay for, how much they pay, and how the economics are expected to work.

4. I understand my numbers. I know my cash position, burn rate, runway, revenue, major expenses, and key financial assumptions.

5. I understand my market. I can explain my target market, competitors, customer alternatives, market size, and why the opportunity can grow.

6. I know what the funding will accomplish. I can connect the amount I am raising to specific milestones rather than simply saying I need money to grow.

7. My team can execute the next stage. I know the team’s strengths and the important capabilities we still need.

8. My ownership and legal structure are organized. My cap table, corporate records, founder agreements, contracts, and IP ownership are reasonably prepared.

9. I know which investors I should approach. I am targeting investors whose stage, industry interests, geography, check size, and expertise fit my company.

10. I can explain what happens if I do not raise. I understand my alternatives and what the company can accomplish with its existing resources.

If you cannot check most of these boxes, that does not mean your startup is failing.

It means you have identified the work that should happen before the fundraising process becomes the primary focus.

GrowthCraft’s Role in Funding Readiness

This is where funding readiness fits into the broader work GrowthCraft provides for early-stage, first-time founders.

GrowthCraft’s approach is not simply about helping a founder create a pitch deck and start asking investors for money. The more important question is whether the company is ready for the scrutiny that comes with outside capital.

That means looking at the business as a whole: the customer and market, business model, financial structure, legal protection, operating priorities, and founder decision-making.

GrowthCraft can serve as a resource for founders working through those questions before they begin a serious fundraising process. The goal is not to make every startup investor-ready immediately. The goal is to help founders understand what needs to be true before outside capital is likely to create meaningful value.

Sometimes the right answer is to raise money now.

Sometimes the right answer is to spend the next six months proving customer demand, refining the business model, cleaning up the financials, protecting intellectual property, or reaching a specific operating milestone first.

Knowing the difference is part of being ready.

Final Thought: Raise Money Because You Are Ready to Use It

The strongest reason to raise startup funding is not that your bank account is getting low.

It is that you have learned enough about your business to know what additional capital can accomplish.

You understand the customer. You have evidence of demand. You know how the business can make money. You understand the market. You know your numbers. Your team is capable of executing the next stage. Your legal and ownership structure can withstand due diligence. Most importantly, you have a specific reason that additional capital should make the company substantially stronger.

Fundraising is not a substitute for figuring out the business.

It is a tool for accelerating a business that is beginning to demonstrate that it works.

For an early-stage founder, that distinction can save time, money, ownership, and a great deal of frustration.

Frequently Asked Questions

How much revenue does a startup need before raising money?

There is no universal revenue threshold for raising startup funding. Some startups raise before generating revenue because they require substantial development, research, regulatory work, or other upfront investment. The more important question is whether you have credible evidence supporting your assumptions and a clear reason why additional capital is needed now.

Should I raise money before I have product-market fit?

Sometimes. Early-stage investors may fund companies before product-market fit if the opportunity, team, technology, market, and early evidence are compelling. However, raising substantial capital before understanding your customer can increase the cost of experimentation. Founders should be clear about what they have validated and what they still need to learn.

What financial information do investors expect?

Investors will typically want to understand your current financial position, ownership structure, revenue and expenses where applicable, cash burn, runway, financial projections, and how you intend to use the funding. The SEC specifically identifies financial statements, capitalization tables, runway calculations, and use-of-proceeds plans as important capital-raising preparation.

Do I need a pitch deck before talking to investors?

A formal pitch deck is not necessarily required for every early conversation, but you should be able to clearly explain your problem, customer, solution, market, traction, business model, team, and funding requirements. Once you begin a formal fundraising process, a well-structured deck becomes an important communication tool.

What should I do if my startup is not ready to raise money?

Turn the gaps into milestones. If customer demand is weak, focus on customer validation. If the business model is unclear, test pricing and purchasing behavior. If the financial model is weak, build a realistic cash-flow forecast. If your legal or IP structure is incomplete, address it before due diligence. Being “not ready” is useful information when you know exactly what needs to change.

Recommended Source Materials

For readers who want to go deeper, these are strong reference resources:

How to Know If Your Startup Is Actually Ready to Raise Money Read More »

Investor Money vs. Go-To-Market First: How Startup Founders Should Decide on One of the First Real Decisions They Face

Investor Money vs. Go-To-Market First:

Investor Money vs. Go-To-Market First: How Startup Founders Should Decide on One of the First Real Decisions They Face

How Startup Founders Should
Decide on One of the First Real Decisions They Face

For first-time and early-stage founders, few decisions feel as consequential as this one:
Do we raise investor money early, or do we focus on building a go-to-market strategy and grow from customer revenue?

The startup ecosystem often frames this choice as binary, but in reality, it’s a strategic continuum. Many iconic companies raised venture capital early. Just as many built meaningful traction, revenue, and leverage before taking a dollar of outside funding.

Understanding the trade-offs matters because this decision shapes how you build your product, how you hire, how fast you move, and how much control you retain.

This article breaks down both paths using Y Combinator and General Catalyst, two of the most influential voices in startup formation and scaling,as references to provide well-established thinking. The goal is not to tell you which path is “right,” but to help you choose the one that best fits your market, product, and personal risk tolerance.

Two Fundamentally Different Startup Philosophies

The Investor-First Philosophy

This approach prioritizes raising capital early to move fast, hire aggressively, and scale before competitors. Capital is treated as fuel to buy speed, talent, and market share.

This model is common in:

  • Winner-take-most markets
  • Platform or marketplace businesses
  • Capital-intensive or regulated industries

The Go-To-Market-First Philosophy

A GTM-first strategy focuses on selling early, learning from customers, and funding growth through revenue. Capital efficiency and product-market fit come before scale.

This model is common in:

  • B2B SaaS and services-enabled software
  • Niche or vertical solutions
  • Founder-led sales motions

Most startups eventually blend these approaches, but the order matters more than founders often realize.

The Case for Raising Investor Money Early

1. Speed Can Be a Competitive Advantage

In certain markets, speed matters more than efficiency. Venture capital allows startups to:

  • Hire ahead of revenue
  • Invest heavily in product and marketing
  • Expand geographically or vertically faster

If network effects or data advantages compound over time, moving slowly can mean losing permanently.

General Catalyst often emphasizes that capital is a tool to accelerate proven momentum, particularly when markets reward scale. Their approach frames capital not as validation, but as leverage.

2. Access to Talent, Networks, and Pattern Recognition

Strong investors bring more than capital. They bring:

  • Customer and partner introductions
  • Help recruiting senior leaders
  • Experience from similar companies at similar stages

Your capital investment partner should describe its role as supporting founders “beyond capital,” particularly in go-to-market execution, hiring, and operational scale. For founders without deep operating networks, this can significantly shorten learning curves.

3. Long Runways Enable Bigger Bets

Some products simply cannot be built on early revenue alone. Deep tech, infrastructure, healthcare, and hardware often require years of development before monetization.

Venture capital allows founders to:

  • Absorb early losses
  • Invest in long-term R&D
  • Build defensible technology before revenue scales

In these cases, GTM-first is often unrealistic.

4. Signaling and Credibility

While not always rational, market perception matters. Funding from well-known firms can:

  • Increase trust with enterprise buyers
  • Attract stronger candidates
  • Create inbound interest from partners

This signaling effect can materially change how quickly doors open.

The Downsides of Raising Investor Money

1. Dilution and Control Trade-Offs

Every round trades ownership for capital. Over time, dilution compounds. More importantly, governance can change:

  • Boards gain influence
  • Growth expectations increase
  • Strategic optionality narrows

Founders often underestimate how quickly their company’s priorities can shift after funding.

2. Pressure to Scale Before You’re Ready

One of the most common failure modes in venture-backed startups is premature scaling. Capital can mask:

  • Weak product-market fit
  • Inefficient acquisition channels
  • Poor retention

Y Combinator has repeatedly warned founders that growth without real customer pull is fragile. Scaling too early often locks in the wrong product or GTM motion.

3. Fundraising Becomes a Job

Raising capital is time-consuming and mentally draining. Paul Graham, co-founder of Y Combinator, famously points out that fundraising rewards founders who run structured, parallel processes and understand investor psychology.

That time almost always comes at the expense of:

  • Talking to customers
  • Improving the product
  • Closing actual deals

4. Exit Expectations Change the Game

Venture capital comes with expectations of large outcomes. That can:

  • Push companies toward high-risk growth strategies
  • Eliminate viable “small but profitable” outcomes
  • Force exits that don’t align with founder goals

Not every founder wants to build a billion-dollar company, and that’s okay.

The Case for a Go-To-Market-First Strategy

1. Customers Are the Best Validation

A GTM-first approach forces founders to answer the hardest questions early:

  • Who is the buyer?
  • What problem do they pay to solve?
  • How long does it take to close?
  • Why do they stay?

A lot of consulting firms repeatedly emphasize talking to users and doing “things that don’t scale” early. Those conversations shape better products than pitch decks ever will.

2. Capital Efficiency Builds Stronger Businesses

When revenue matters, discipline follows. GTM-first companies learn:

  • True customer acquisition costs
  • Realistic lifetime value
  • Sustainable pricing

This often leads to healthier companies that can endure downturns and truly adapt to market shifts, not just survive them.

3. Founders Retain Control and Optionality

Bootstrapping or delaying funding preserves:

  • Equity ownership
  • Strategic freedom
  • Pace control

Revenue gives founders leverage. When you eventually raise, you do so on better terms and from a position of strength…not desperation.

4. GTM Muscle Compounds

Selling early builds institutional knowledge:

  • Messaging that resonates
  • Repeatable sales motions
  • Onboarding and retention insights

These capabilities compound and dramatically increase valuation if and when you raise capital.

The Risks of a GTM-First Approach

1. Slower Scaling

Without capital, growth is naturally constrained. This can be dangerous in fast-moving markets or where competitors are heavily funded.

2. Founder Burnout

Early GTM-first startups often rely heavily on founders to sell, support, and build simultaneously. Without relief, this can limit long-term scalability.

3. Missed Market Windows

In markets driven by network effects or rapid consolidation, moving too slowly can mean losing relevance entirely.

A Practical Decision Framework for Founders

Ask yourself:

Market Dynamics

  • Is this a winner-take-most market?
  • Do network effects or data moats matter?

Capital Intensity

  • Can early customers fund development?
  • Are there regulatory or infrastructure costs?

Sales Motion

  • Can founders sell this product themselves?
  • Is there early willingness to pay?

Personal Goals

  • Do you value control or speed more?
  • Are you building a company or swinging for a category?

Your answers point clearly toward one strategy or a hybrid.

The Hybrid Path: GTM First, Capital Second

Many of the strongest startups today validate through GTM first, then raise capital to scale what’s already working.

General Catalyst frequently backs companies that demonstrate:

  • Clear customer demand
  • Repeatable GTM motions
  • Strong unit economics

This approach reduces risk for both founders and investors and aligns incentives around sustainable growth.

Final Thoughts

Raising investor money is not a badge of honor. Bootstrapping is not a limitation. They are tools.

Y Combinator’s guidance consistently reminds founders that customers matter more than capital. General Catalyst’s perspective reinforces that capital is most powerful when applied to proven momentum.

The best founders understand both…and choose intentionally.

If you can sell early, do it. If you must raise to build, do it wisely. And if you can combine the two, you give yourself the greatest leverage of all.

Investor Money vs. Go-To-Market First: Read More »

a dna helix made out of dolla rbills

4 Answers to Key SBIR Questions in 2025

4 Answers to Key SBIR Questions in 2025

a dna helix made out of dolla rbills

There have been a lot of reports in the news recently about changes in Federal grant policies. Even those who are only casual tourists to this world will have heard about pauses in grant reviews at the various funding agencies, potentially drastic cuts in funding levels, and other general rumblings that the sky is about to fall.
The policies of the new administration vis-à-vis R&D funding are still being finalized, instituted—and, in some cases, litigated.  But enough information has now emerged that we can start to draw some reasonable inferences about what all this means for the ~ $4.5B in SBIR/STTR grants that is disbursed every year and that is such an important source of non-dilutive funding for high tech startups.  And the answer is…not much.

That’s right.  Carry on, nothing to see here, folks.

At AwardIT, we have been getting regularly contacted over the past month or so, with varying levels of panic, about potential changes in SBIR/STTR policies. We thought it might help to gather up a few of the questions and try to answer them as clearly and concisely as possible. 

Question 1: I’ve heard that the NIH is going to limit Indirect Costs to 15%?  Isn’t that a big deal?

Answer: for Institutes of Higher Education (IHE), it sure is. They have become accustomed to getting >50% (in some cases, up to ~90%) on top of the dollars that directly support the research program being funded at their Institution.  That is going to be a wrench to do without—which is why they are challenging the ruling in the courts.

We are grant consultants, not lawyers, but FWIW our view is that this is a legal battle the IHEs are unlikely to win.  The executive branch really does have Constitutional authority in these matters. But no matter how that ruling shakes out, it seems clear that this change in IC rates is intended ONLY for IHE grants.  We’ve read the NIH Guidance on the recent change in IC policy NOT-OD-25-068: Supplemental Guidance to the 2024 NIH Grants Policy Statement: Indirect Cost Rates (we do stuff like this so you don’t have to).  The CFRs cited in that Guidance, such as CF 75.414, make it clear that IHEs and nonprofits are regulated under a different budgetary policy than SBs and for-profit entities.  

The above is, more or less, the same policy for the other agencies with the largest SBIR/STTR budgets (NSF, DOE, DOD)

Takeaway: Indirect Cost rates for SBIR grants, as far as we can tell right now, can be expected to remain in the 20%-40% range, where they have always been.

Question 2: is overall funding support for SBIR/STTR going down?  

Answer: for Institutes of Higher Education (IHE), it sure is. They have become accustomed to getting >50% (in some cases, up to ~90%) on top of the dollars that directly support the research program being funded at their Institution.  That is going to be a wrench to do without—which is why they are challenging the ruling in the courts.

We are grant consultants, not lawyers, but FWIW our view is that this is a legal battle the IHEs are unlikely to win.  The executive branch really does have Constitutional authority in these matters. But no matter how that ruling shakes out, it seems clear that this change in IC rates is intended ONLY for IHE grants.  We’ve read the NIH Guidance on the recent change in IC policy NOT-OD-25-068: Supplemental Guidance to the 2024 NIH Grants Policy Statement: Indirect Cost Rates (we do stuff like this so you don’t have to).  The CFRs cited in that Guidance, such as CF 75.414, make it clear that IHEs and nonprofits are regulated under a different budgetary policy than SBs and for-profit entities.  

The above is, more or less, the same policy for the other agencies with the largest SBIR/STTR budgets (NSF, DOE, DOD)

Takeaway: Indirect Cost rates for SBIR grants, as far as we can tell right now, can be expected to remain in the 20%-40% range, where they have always been.

Question 3: review/funding of my grant has been delayed.  How long will I have to wait?

Answer: Applicants at all of the big 4 agencies have experienced some delay in processing of grants since January.  This is not that unusual during a change in Administration.  It’s been a little more pronounced (and announced) this time around, but the reality is a lot of the focus for the internal audit is on academic grant funding, not SBIR/STTR grants.  As fas as SBIR/STTR goes: the latest feedback from NIH  is that study sections are being convened, reviews are being issued, happy grants are getting funded.  Similarly, at DOD SBIR grants have been largely unaffected (Pentagon says small business programs not part of grant funding pause)

The exception is NSF, which is currently undergoing a significant transformation in its overall structure. Budget cuts and personnel layoffs have already taken place at the agency, and more are likely to follow. In the latest twist, on April 24 the NSF director Sethuraman Panchanathan announced he would resign (Trump’s first-term pick to run the National Science Foundation quits: ‘I have done all I can’). 

So much change was sure to have an impact and the agency’s April 16 announcement that grant review would be paused was perhaps not a huge surprise.  But again, SBIR/STTR seems to be largely sheltered so far: Project Pitches and applications for the upcoming July 2 NSF SBIR/STTR application deadline are still being accepted.  Most importantly, as of this writing, the NSF budget for SBIR/STTR grants remains where it was (see above).

Takeaway: if you have a grant application in the queue for Spring 2025, expect some amount of slowdown in getting your review or for funding to flow.  This is especially true at NSF.  But overall things are still moving forward.

Question 4: You are telling me that things are OK for now. But can’t SBIR grants be abolished by Executive Order?  Could they just vanish overnight?

Answer: In a word–no. The SBIR program was established by an Act of Congress over 40 years ago. It has been renewed, with bipartisan support, every 3 years since that time. Our representatives may not be able to agree on much, but they seem to consistently agree on maintaining the SBIR/STTR program, and Federal law cannot be changed just with the famous “stroke of a pen”.  

In summary: there is no doubt that US R&D funding priorities have changed with the advent of a new administration. What else is new? The answer is to stay flexible and shift grant strategy in response to the new realities. We at AwardIT have been grant consultants for a long time and have seen this happen more than once. Despite alarmist reports, it does not appear that any of the recent news will have much impact on Federal agencies overall SBIR/STTR spending or review processes. Onward!

Want to learn more?  Reach out to AwardIT at https://awardit.net/ or email me at neal@awardit.net.  It’s a world of smart ideas, we look forward to learning more about yours.

4 Answers to Key SBIR Questions in 2025 Read More »

Scroll to Top